Serum cytokines associated with severity and complications of kala-azar
- PMID: 23683334
- PMCID: PMC4001482
- DOI: 10.1179/2047773213Y.0000000078
Serum cytokines associated with severity and complications of kala-azar
Abstract
Objectives: Recent clinical data suggest that severe kala-azar (or visceral leishmaniasis) is an exaggerated innate immune response mediated by inflammatory cytokines, leading to a systemic inflammatory syndrome similar to what is observed in malaria, sepsis and other diseases. We tested this hypothesis by measuring serum cytokines in individuals with kala-azar.
Methods: We compared patients with severe kala-azar (i.e. hemorrhagic manifestations, n = 38) with patients without evidence of hemorrhage (n = 96). We conducted a detailed clinical and laboratory evaluation, measuring serum IL-1beta, IL-6, IL-8, IL-10, IL-12, interferon-gamma, and TNF-alpha, and markers of disseminated intravascular coagulation (DIC).
Results: Infants had higher levels of inflammatory cytokines, while HIV-infected patients had lower concentrations of IL-10 and interferon-gamma. Higher levels of IL-6, interferon-gamma, and IL-8 were found among deceased patients. IL-8 and interferon-gamma were independently associated with bleeding. Several cytokines were associated with different signs of severe clinical and laboratory manifestations, including DIC. IL-6 was highly positively and independently associated with IL-1beta, IL-8, IL-10, and negatively associated with TNF-alpha. IL-1beta and TNF-alpha were also highly independently associated with disease severity.
Conclusion: In its severe form, kala-azar, a neglected tropical disease, initiates a systemic inflammatory response that leads to DIC and other manifestations. Children may have higher risk of death due to the more intense cytokine release. The data supports the notion that IL-6 is the central cytokine that is associated with lethal disease, but interferon-gamma, IL1beta, IL-8, and TNF-alpha are also involved with disease severity. Inhibition of IL-6 is a potential target of adjuvant therapy for severe or pediatric forms of this disease.
Figures






Similar articles
-
Potential role for interleukin-10 in the immunosuppression associated with kala azar.J Clin Invest. 1993 Dec;92(6):2626-32. doi: 10.1172/JCI116878. J Clin Invest. 1993. PMID: 8254019 Free PMC article.
-
Elevated levels of interferon-gamma, interleukin-10, and interleukin-6 during active disease in Indian kala azar.Clin Immunol. 2006 Jun;119(3):339-45. doi: 10.1016/j.clim.2006.01.017. Epub 2006 Mar 15. Clin Immunol. 2006. PMID: 16540374 Clinical Trial.
-
Multiplex analysis of circulating cytokines in the sera of patients with different clinical forms of visceral leishmaniasis.Cytometry A. 2006 May;69(5):353-8. doi: 10.1002/cyto.a.20256. Cytometry A. 2006. PMID: 16604536
-
The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis.Medicine (Baltimore). 2019 May;98(22):e15844. doi: 10.1097/MD.0000000000015844. Medicine (Baltimore). 2019. PMID: 31145332 Free PMC article.
-
Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?Clin Med Res. 2006 Dec;4(4):294-309. doi: 10.3121/cmr.4.4.294. Clin Med Res. 2006. PMID: 17210978 Free PMC article. Review.
Cited by
-
Immunomodulatory and Antileishmanial Activity of Phenylpropanoid Dimers Isolated from Nectandra leucantha.J Nat Prod. 2015 Apr 24;78(4):653-7. doi: 10.1021/np500809a. Epub 2015 Apr 2. J Nat Prod. 2015. PMID: 25835647 Free PMC article.
-
New record of preclinical diagnosis of American visceral leishmaniasis in Amazonian Brazil encourages optimizing disease control.Parasite Epidemiol Control. 2020 May 8;10:e00154. doi: 10.1016/j.parepi.2020.e00154. eCollection 2020 Aug. Parasite Epidemiol Control. 2020. PMID: 32435706 Free PMC article.
-
Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease.Front Immunol. 2014 Jun 13;5:272. doi: 10.3389/fimmu.2014.00272. eCollection 2014. Front Immunol. 2014. PMID: 24982655 Free PMC article. Review.
-
Visceral Leishmaniasis Patients Display Altered Composition and Maturity of Neutrophils as well as Impaired Neutrophil Effector Functions.Front Immunol. 2016 Nov 29;7:517. doi: 10.3389/fimmu.2016.00517. eCollection 2016. Front Immunol. 2016. PMID: 27965662 Free PMC article.
-
Nutritional status and vitamin A and zinc levels in patients with kala-azar in Piauí, Brazil.Rev Soc Bras Med Trop. 2021 Sep 6;54:e08002020. doi: 10.1590/0037-8682-0800-2020. eCollection 2021. Rev Soc Bras Med Trop. 2021. PMID: 34495261 Free PMC article.
References
-
- Herwaldt BL. Leishmaniasis. Lancet. 1999;354(9185):1191–9. - PubMed
-
- Seaman J, Mercer AJ, Sondorp HE, Herwaldt BL. Epidemic visceral leishmaniasis in southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources. Ann Intern Med. 1996;124(7):664–72. - PubMed
-
- Werneck GL, Batista MS, Gomes JR, Costa DL, Costa CH. Prognostic factors for death from visceral leishmaniasis in Teresina, Brazil. Infection. 2003;31(3):174–7. - PubMed
-
- Abdelmoula MS, M’Hamdi Z, Amri F, Tebib N, Ben Turkia H, Ben Dridi MF. [Visceral leishmaniasis in children: prognostic factors]. Tunis Med. 2003;81(8):535–9. French. - PubMed
-
- Collin SDR, Ritmeijer K, Keus K, Melaku Y, Kipngetich S, Davies C. Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan. Clin Infect Dis. 2004;38(5):612–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical